Clinical Trials Logo

Clinical Trial Summary

This study is being conducted to determine the efficacy and safety of povorcitinib in participants with nonsegmental vitiligo.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06113445
Study type Interventional
Source Incyte Corporation
Contact Incyte Corporation Call Center (US)
Phone 1.855.463.3463
Email medinfo@incyte.com
Status Recruiting
Phase Phase 3
Start date November 29, 2023
Completion date May 8, 2027

See also
  Status Clinical Trial Phase
Recruiting NCT06113471 - A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) Phase 3
Completed NCT04818346 - A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Vitiligo Phase 2